Insider · CIK 0001927064
Neil Cashman
Files at PMN (ProMIS Neurosciences Inc.). First filing Feb 12, 2025, latest Feb 12, 2025.
In brief
Neil Cashman files SEC Form 4 as officer and director at PMN (ProMIS Neurosciences Inc.). Since Feb 12, 2025, Neil Cashman has reported 1 open-market buy worth $15k and 0 open-market sells worth $0, the latest filed on Feb 12, 2025.
A track record needs three past buys with six months of prices behind them; Neil Cashman has 0, so none is measured yet.
The newest scored trade: bought $15k of PMN on Feb 10, 2025, filed Feb 12, 2025, scored 25 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PMN: ProMIS Neurosciences Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 25Weak | PMNbuy ProMIS Neurosciences Inc. | $15k 15,000 shares | +928% | - |
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 20, 2026 | PMN ProMIS Neurosciences Inc. | AGrant or award Option (right to buy)derivative | +50,000 | $0.00 | $0 | 50,000 | May 22, 2026 |
| Feb 3, 2026 | PMN ProMIS Neurosciences Inc. | AGrant or award Common Sharesindirect: By Research Capital Corporation | +4,122 | $12.13 | $50k | 4,122 | Feb 5, 2026 |
| Feb 3, 2026 | PMN ProMIS Neurosciences Inc. | AGrant or award Warrants to purchase Common Sharesderivativeindirect: By Research Capital Corporation | +4,122 | - | - | 4,122 | Feb 5, 2026 |
| Sep 22, 2025 | PMN ProMIS Neurosciences Inc. | AGrant or award Option (right to buy)derivative | +165,000 | $0.00 | $0 | 165,000 | Sep 24, 2025 |
| Feb 10, 2025 | PMN ProMIS Neurosciences Inc. | POpen-market purchase Common Sharesindirect: By his spouse | +15,000 | $0.97 | $15k | 16,617 | Feb 12, 2025 |
| Nov 18, 2024 | PMN ProMIS Neurosciences Inc. | AGrant or award Option (right to buy)derivative | +200,000 | $0.00 | $0 | 200,000 | Nov 20, 2024 |
| Oct 26, 2023 | PMN ProMIS Neurosciences Inc. | AGrant or award Option (right to buy)derivative | +12,500 | $0.00 | $0 | 12,500 | Oct 30, 2023 |
Questions about Neil Cashman
Answered from the filings on this page, as of the latest one.
Is Neil Cashman buying or selling?
Not in the last 12 months. Neil Cashman's latest open-market trade on SEC Form 4 was bought $15k of PMN on Feb 10, 2025.
How did Neil Cashman's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Neil Cashman has 0.
Where does Neil Cashman file Form 4?
Neil Cashman has filed Form 4 at PMN (ProMIS Neurosciences Inc.) as Chief Scientific Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.